APO Research, Inc.

APO RESEARCH · REPORT

NAD+ Booster Capsule

Selected research

Market Structure

Global NAD+ Booster Capsule Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global NAD+ Booster Capsule market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for NAD+ Booster Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NAD+ Booster Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NAD+ Booster Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for NAD+ Booster Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of NAD+ Booster Capsule include EffePharm, Kingdomway, GeneHarbor, Bontac, NOMON Co., Ltd. (Teijin), Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), Maac10 Formulas, Herbalmax and Genex Formulas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global NAD+ Booster Capsule market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NAD+ Booster Capsule and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NAD+ Booster Capsule sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NAD+ Booster Capsule market size, projected growth trends, production technologies, key applications, and end-use industries.

NAD+ Booster Capsule Segment by Company

EffePharm

Kingdomway

GeneHarbor

Bontac

NOMON Co., Ltd. (Teijin)

Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)

Maac10 Formulas

Herbalmax

Genex Formulas

EZZ

Elysium Health

Chromadex

CELFULL

NAD+ Booster Capsule Segment by Type

Content <98%

Content ≥98%

NAD+ Booster Capsule Segment by Application

Health Care Products

Beauty Products

Others

NAD+ Booster Capsule Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAD+ Booster Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NAD+ Booster Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAD+ Booster Capsule.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the NAD+ Booster Capsule market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of NAD+ Booster Capsule manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of NAD+ Booster Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of NAD+ Booster Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. NAD+ Booster Capsule Industry Trends Table 2. NAD+ Booster Capsule Industry Drivers Table 3. NAD+ Booster Capsule Industry Opportunities and Challenges Table 4. NAD+ Booster Capsule Industry Restraints Table 5. Global NAD+ Booster Capsule Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global NAD+ Booster Capsule Revenue Market Share by Manufacturers (2021-2026) Table 7. Global NAD+ Booster Capsule Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global NAD+ Booster Capsule Sales Market Share by Manufacturers Table 9. Global NAD+ Booster Capsule Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global NAD+ Booster Capsule Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global NAD+ Booster Capsule Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global NAD+ Booster Capsule Manufacturers, Product Type & Application Table 13. Global NAD+ Booster Capsule Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global NAD+ Booster Capsule by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Content <98% Table 17. Major Manufacturers of Content ≥98% Table 18. Global NAD+ Booster Capsule Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global NAD+ Booster Capsule Sales by Type (2021-2026) & (K Units) Table 20. Global NAD+ Booster Capsule Sales by Type (2027-2032) & (K Units) Table 21. Global NAD+ Booster Capsule Sales Market Share by Type (2021-2026) Table 22. Global NAD+ Booster Capsule Sales Market Share by Type (2027-2032) Table 23. Global NAD+ Booster Capsule Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global NAD+ Booster Capsule Revenue by Type (2021-2026) & (K Units) Table 25. Global NAD+ Booster Capsule Revenue by Type (2027-2032) & (K Units) Table 26. Global NAD+ Booster Capsule Revenue Market Share by Type (2021-2026) Table 27. Global NAD+ Booster Capsule Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Health Care Products Table 29. Major Manufacturers of Beauty Products Table 30. Major Manufacturers of Others Table 31. Global NAD+ Booster Capsule Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global NAD+ Booster Capsule Sales by Application (2021-2026) & (K Units) Table 33. Global NAD+ Booster Capsule Sales by Application (2027-2032) & (K Units) Table 34. Global NAD+ Booster Capsule Sales Market Share by Application (2021-2026) Table 35. Global NAD+ Booster Capsule Sales Market Share by Application (2027-2032) Table 36. Global NAD+ Booster Capsule Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global NAD+ Booster Capsule Revenue by Application (2021-2026) & (K Units) Table 38. Global NAD+ Booster Capsule Revenue by Application (2027-2032) & (K Units) Table 39. Global NAD+ Booster Capsule Revenue Market Share by Application (2021-2026) Table 40. Global NAD+ Booster Capsule Revenue Market Share by Application (2027-2032) Table 41. Global NAD+ Booster Capsule Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global NAD+ Booster Capsule Sales by Region (2021-2026) & (K Units) Table 43. Global NAD+ Booster Capsule Sales Market Share by Region (2021-2026) Table 44. Global NAD+ Booster Capsule Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global NAD+ Booster Capsule Sales Forecasted Market Share by Region (2027-2032) Table 46. North America NAD+ Booster Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America NAD+ Booster Capsule Sales by Country (2021-2026) & (K Units) Table 48. North America NAD+ Booster Capsule Sales by Country (2027-2032) & (K Units) Table 49. Europe NAD+ Booster Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe NAD+ Booster Capsule Sales by Country (2021-2026) & (K Units) Table 51. Europe NAD+ Booster Capsule Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific NAD+ Booster Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific NAD+ Booster Capsule Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific NAD+ Booster Capsule Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa NAD+ Booster Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa NAD+ Booster Capsule Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa NAD+ Booster Capsule Sales by Country (2027-2032) & (K Units) Table 58. Global NAD+ Booster Capsule Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global NAD+ Booster Capsule Revenue by Region (2021-2026) & (US$ Million) Table 60. Global NAD+ Booster Capsule Revenue by Region (2027-2032) & (US$ Million) Table 61. Global NAD+ Booster Capsule Revenue Market Share by Region (2021-2026) Table 62. Global NAD+ Booster Capsule Revenue Market Share by Region (2027-2032) Table 63. EffePharm Company Information Table 64. EffePharm Business Overview Table 65. EffePharm NAD+ Booster Capsule Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. EffePharm NAD+ Booster Capsule Product Portfolio Table 67. EffePharm Recent Development Table 68. Kingdomway Company Information Table 69. Kingdomway Business Overview Table 70. Kingdomway NAD+ Booster Capsule Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Kingdomway NAD+ Booster Capsule Product Portfolio Table 72. Kingdomway Recent Development Table 73. GeneHarbor Company Information Table 74. GeneHarbor Business Overview Table 75. GeneHarbor NAD+ Booster Capsule Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. GeneHarbor NAD+ Booster Capsule Product Portfolio Table 77. GeneHarbor Recent Development Table 78. Bontac Company Information Table 79. Bontac Business Overview Table 80. Bontac NAD+ Booster Capsule Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bontac NAD+ Booster Capsule Product Portfolio Table 82. Bontac Recent Development Table 83. NOMON Co., Ltd. (Teijin) Company Information Table 84. NOMON Co., Ltd. (Teijin) Business Overview Table 85. NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Product Portfolio Table 87. NOMON Co., Ltd. (Teijin) Recent Development Table 88. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information Table 89. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview Table 90. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Product Portfolio Table 92. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Development Table 93. Maac10 Formulas Company Information Table 94. Maac10 Formulas Business Overview Table 95. Maac10 Formulas NAD+ Booster Capsule Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Maac10 Formulas NAD+ Booster Capsule Product Portfolio Table 97. Maac10 Formulas Recent Development Table 98. Herbalmax Company Information Table 99. Herbalmax Business Overview Table 100. Herbalmax NAD+ Booster Capsule Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Herbalmax NAD+ Booster Capsule Product Portfolio Table 102. Herbalmax Recent Development Table 103. Genex Formulas Company Information Table 104. Genex Formulas Business Overview Table 105. Genex Formulas NAD+ Booster Capsule Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Genex Formulas NAD+ Booster Capsule Product Portfolio Table 107. Genex Formulas Recent Development Table 108. EZZ Company Information Table 109. EZZ Business Overview Table 110. EZZ NAD+ Booster Capsule Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. EZZ NAD+ Booster Capsule Product Portfolio Table 112. EZZ Recent Development Table 113. Elysium Health Company Information Table 114. Elysium Health Business Overview Table 115. Elysium Health NAD+ Booster Capsule Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Elysium Health NAD+ Booster Capsule Product Portfolio Table 117. Elysium Health Recent Development Table 118. Chromadex Company Information Table 119. Chromadex Business Overview Table 120. Chromadex NAD+ Booster Capsule Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Chromadex NAD+ Booster Capsule Product Portfolio Table 122. Chromadex Recent Development Table 123. CELFULL Company Information Table 124. CELFULL Business Overview Table 125. CELFULL NAD+ Booster Capsule Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. CELFULL NAD+ Booster Capsule Product Portfolio Table 127. CELFULL Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. NAD+ Booster Capsule Distributors List Table 131. NAD+ Booster Capsule Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. NAD+ Booster Capsule Product Image Figure 2. Global NAD+ Booster Capsule Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NAD+ Booster Capsule Market Size (2021-2032) & (US$ Million) Figure 4. Global NAD+ Booster Capsule Sales (2021-2032) & (K Units) Figure 5. Global NAD+ Booster Capsule Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 NAD+ Booster Capsule Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Content <98% Image Figure 9. Content ≥98% Image Figure 10. Global NAD+ Booster Capsule Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global NAD+ Booster Capsule Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global NAD+ Booster Capsule Sales Market Share by Type (2021-2032) Figure 13. Global NAD+ Booster Capsule Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global NAD+ Booster Capsule Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global NAD+ Booster Capsule Revenue Market Share by Type (2021-2032) Figure 16. Health Care Products Image Figure 17. Beauty Products Image Figure 18. Others Image Figure 19. Global NAD+ Booster Capsule Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global NAD+ Booster Capsule Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global NAD+ Booster Capsule Sales Market Share by Application (2021-2032) Figure 22. Global NAD+ Booster Capsule Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global NAD+ Booster Capsule Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global NAD+ Booster Capsule Revenue Market Share by Application (2021-2032) Figure 25. North America NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America NAD+ Booster Capsule Sales Market Share by Country (2021-2032) Figure 27. U.S. NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe NAD+ Booster Capsule Sales Market Share by Country (2021-2032) Figure 32. Germany NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific NAD+ Booster Capsule Sales Market Share by Country (2021-2032) Figure 39. China NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa NAD+ Booster Capsule Sales Market Share by Country (2021-2032) Figure 47. Brazil NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile NAD+ Booster Capsule Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global NAD+ Booster Capsule Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global NAD+ Booster Capsule Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America NAD+ Booster Capsule Revenue (2021-2032) & (US$ Million) Figure 58. North America NAD+ Booster Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe NAD+ Booster Capsule Revenue (2021-2032) & (US$ Million) Figure 60. Europe NAD+ Booster Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific NAD+ Booster Capsule Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific NAD+ Booster Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa NAD+ Booster Capsule Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa NAD+ Booster Capsule Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. NAD+ Booster Capsule Value Chain Figure 66. Manufacturing Cost Structure Figure 67. NAD+ Booster Capsule Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Content <98%
  • Content ≥98%
Applications
  • Health Care Products
  • Beauty Products
  • Others
Companies covered
  • EffePharm
  • Kingdomway
  • GeneHarbor
  • Bontac
  • NOMON Co., Ltd. (Teijin)
  • Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
  • Maac10 Formulas
  • Herbalmax
  • Genex Formulas
  • EZZ
  • Elysium Health
  • Chromadex
  • CELFULL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global NAD+ Booster Capsule Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global NAD+ Booster Capsule Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global NAD+ Booster Capsule Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global NAD+ Booster Capsule Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global NAD+ Booster Capsule Market Dynamics
  1. 2.1 NAD+ Booster Capsule Industry Trends
  2. 2.2 NAD+ Booster Capsule Industry Drivers
  3. 2.3 NAD+ Booster Capsule Industry Opportunities and Challenges
  4. 2.4 NAD+ Booster Capsule Industry Restraints
3 NAD+ Booster Capsule Market by Manufacturers
  1. 3.1 Global NAD+ Booster Capsule Revenue by Manufacturers (2021-2026)
  2. 3.2 Global NAD+ Booster Capsule Sales by Manufacturers (2021-2026)
  3. 3.3 Global NAD+ Booster Capsule Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global NAD+ Booster Capsule Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global NAD+ Booster Capsule Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global NAD+ Booster Capsule Manufacturers, Product Type & Application
  7. 3.7 Global NAD+ Booster Capsule Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global NAD+ Booster Capsule Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 NAD+ Booster Capsule Players Market Share by Revenue in 2025
  11. 3.8.3 2025 NAD+ Booster Capsule Tier 1, Tier 2, and Tier 3
4 NAD+ Booster Capsule Market by Type
  1. 4.1 NAD+ Booster Capsule Type Introduction
  2. 4.1.1 Content <98%
  3. 4.1.2 Content ≥98%
  4. 4.2 Global NAD+ Booster Capsule Sales by Type
  5. 4.2.1 Global NAD+ Booster Capsule Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global NAD+ Booster Capsule Sales by Type (2021-2032)
  7. 4.2.3 Global NAD+ Booster Capsule Sales Market Share by Type (2021-2032)
  8. 4.3 Global NAD+ Booster Capsule Revenue by Type
  9. 4.3.1 Global NAD+ Booster Capsule Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global NAD+ Booster Capsule Revenue by Type (2021-2032)
  11. 4.3.3 Global NAD+ Booster Capsule Revenue Market Share by Type (2021-2032)
5 NAD+ Booster Capsule Market by Application
  1. 5.1 NAD+ Booster Capsule Application Introduction
  2. 5.1.1 Health Care Products
  3. 5.1.2 Beauty Products
  4. 5.1.3 Others
  5. 5.2 Global NAD+ Booster Capsule Sales by Application
  6. 5.2.1 Global NAD+ Booster Capsule Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global NAD+ Booster Capsule Sales by Application (2021-2032)
  8. 5.2.3 Global NAD+ Booster Capsule Sales Market Share by Application (2021-2032)
  9. 5.3 Global NAD+ Booster Capsule Revenue by Application
  10. 5.3.1 Global NAD+ Booster Capsule Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global NAD+ Booster Capsule Revenue by Application (2021-2032)
  12. 5.3.3 Global NAD+ Booster Capsule Revenue Market Share by Application (2021-2032)
6 Global NAD+ Booster Capsule Sales by Region
  1. 6.1 Global NAD+ Booster Capsule Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global NAD+ Booster Capsule Sales by Region (2021-2032)
  3. 6.2.1 Global NAD+ Booster Capsule Sales by Region (2021-2026)
  4. 6.2.2 Global NAD+ Booster Capsule Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America NAD+ Booster Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America NAD+ Booster Capsule Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe NAD+ Booster Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe NAD+ Booster Capsule Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific NAD+ Booster Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific NAD+ Booster Capsule Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa NAD+ Booster Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa NAD+ Booster Capsule Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global NAD+ Booster Capsule Revenue by Region
  1. 7.1 Global NAD+ Booster Capsule Revenue by Region
  2. 7.1.1 Global NAD+ Booster Capsule Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global NAD+ Booster Capsule Revenue by Region (2021-2026)
  4. 7.1.3 Global NAD+ Booster Capsule Revenue by Region (2027-2032)
  5. 7.1.4 Global NAD+ Booster Capsule Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America NAD+ Booster Capsule Revenue (2021-2032)
  8. 7.2.2 North America NAD+ Booster Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe NAD+ Booster Capsule Revenue (2021-2032)
  11. 7.3.2 Europe NAD+ Booster Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific NAD+ Booster Capsule Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific NAD+ Booster Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa NAD+ Booster Capsule Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa NAD+ Booster Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 EffePharm
  2. 8.1.1 EffePharm Company Information
  3. 8.1.2 EffePharm Business Overview
  4. 8.1.3 EffePharm NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 EffePharm NAD+ Booster Capsule Product Portfolio
  6. 8.1.5 EffePharm Recent Developments
  7. 8.2 Kingdomway
  8. 8.2.1 Kingdomway Company Information
  9. 8.2.2 Kingdomway Business Overview
  10. 8.2.3 Kingdomway NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Kingdomway NAD+ Booster Capsule Product Portfolio
  12. 8.2.5 Kingdomway Recent Developments
  13. 8.3 GeneHarbor
  14. 8.3.1 GeneHarbor Company Information
  15. 8.3.2 GeneHarbor Business Overview
  16. 8.3.3 GeneHarbor NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GeneHarbor NAD+ Booster Capsule Product Portfolio
  18. 8.3.5 GeneHarbor Recent Developments
  19. 8.4 Bontac
  20. 8.4.1 Bontac Company Information
  21. 8.4.2 Bontac Business Overview
  22. 8.4.3 Bontac NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bontac NAD+ Booster Capsule Product Portfolio
  24. 8.4.5 Bontac Recent Developments
  25. 8.5 NOMON Co., Ltd. (Teijin)
  26. 8.5.1 NOMON Co., Ltd. (Teijin) Company Information
  27. 8.5.2 NOMON Co., Ltd. (Teijin) Business Overview
  28. 8.5.3 NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Product Portfolio
  30. 8.5.5 NOMON Co., Ltd. (Teijin) Recent Developments
  31. 8.6 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
  32. 8.6.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information
  33. 8.6.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview
  34. 8.6.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Product Portfolio
  36. 8.6.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments
  37. 8.7 Maac10 Formulas
  38. 8.7.1 Maac10 Formulas Company Information
  39. 8.7.2 Maac10 Formulas Business Overview
  40. 8.7.3 Maac10 Formulas NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Maac10 Formulas NAD+ Booster Capsule Product Portfolio
  42. 8.7.5 Maac10 Formulas Recent Developments
  43. 8.8 Herbalmax
  44. 8.8.1 Herbalmax Company Information
  45. 8.8.2 Herbalmax Business Overview
  46. 8.8.3 Herbalmax NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Herbalmax NAD+ Booster Capsule Product Portfolio
  48. 8.8.5 Herbalmax Recent Developments
  49. 8.9 Genex Formulas
  50. 8.9.1 Genex Formulas Company Information
  51. 8.9.2 Genex Formulas Business Overview
  52. 8.9.3 Genex Formulas NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Genex Formulas NAD+ Booster Capsule Product Portfolio
  54. 8.9.5 Genex Formulas Recent Developments
  55. 8.10 EZZ
  56. 8.10.1 EZZ Company Information
  57. 8.10.2 EZZ Business Overview
  58. 8.10.3 EZZ NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 EZZ NAD+ Booster Capsule Product Portfolio
  60. 8.10.5 EZZ Recent Developments
  61. 8.11 Elysium Health
  62. 8.11.1 Elysium Health Company Information
  63. 8.11.2 Elysium Health Business Overview
  64. 8.11.3 Elysium Health NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Elysium Health NAD+ Booster Capsule Product Portfolio
  66. 8.11.5 Elysium Health Recent Developments
  67. 8.12 Chromadex
  68. 8.12.1 Chromadex Company Information
  69. 8.12.2 Chromadex Business Overview
  70. 8.12.3 Chromadex NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Chromadex NAD+ Booster Capsule Product Portfolio
  72. 8.12.5 Chromadex Recent Developments
  73. 8.13 CELFULL
  74. 8.13.1 CELFULL Company Information
  75. 8.13.2 CELFULL Business Overview
  76. 8.13.3 CELFULL NAD+ Booster Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CELFULL NAD+ Booster Capsule Product Portfolio
  78. 8.13.5 CELFULL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 NAD+ Booster Capsule Value Chain Analysis
  2. 9.1.1 NAD+ Booster Capsule Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 NAD+ Booster Capsule Production Mode & Process
  6. 9.2 NAD+ Booster Capsule Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 NAD+ Booster Capsule Distributors
  9. 9.2.3 NAD+ Booster Capsule Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.